Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' BRUNE K' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 144 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Werner, U; Werner, D; Mundkowski, R; Gillich, M; Brune, K
      Selective and rapid liquid chromatography-mass spectrometry method for thequantification of rofecoxib in pharmacokinetic studies with humans

      JOURNAL OF CHROMATOGRAPHY B
    2. Guhring, H; Tegeder, I; Lotsch, J; Pahl, A; Werner, U; Reeh, PW; Rehse, K; Brune, K; Geisslinger, G
      Role of nitric oxide in zymosan induced paw inflammation and thermal hyperalgesia

      INFLAMMATION RESEARCH
    3. Krebs, S; Dormann, H; Muth-Selbach, U; Hahn, EG; Brune, K; Schneider, HT
      Risperidone-induced cholestatic hepatitis

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    4. Tegeder, I; Niederberger, E; Israr, E; Guhring, H; Brune, K; Euchenhofer, C; Grosch, S; Geisslinger, G
      Inhibition of NF-KB and AP-1 activation by R- and S-flurbiprofen

      FASEB JOURNAL
    5. Tegeder, I; Niederberger, E; Israr, E; Guhring, H; Brune, K; Euchenhofer, C; Grosch, S; Geisslinger, G
      Inhibition of NF-kappa B and AP-1 activation by R- and S-flurbiprofen

      FASEB JOURNAL
    6. Hinz, B; Brune, K; Rau, T; Pahl, A
      Flurbiprofen enantiomers inhibit inducible nitric oxide synthase expression in RAW 264.7 macrophages

      PHARMACEUTICAL RESEARCH
    7. Brune, K; Neubert, A
      Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a pharmacologist's perspective

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    8. Lotsch, J; Muth-Selbach, U; Tegeder, I; Brune, K; Geisslinger, G
      Simultaneous fitting of R- and S-ibuprofen plasma concentrations after oral administration of the racemate

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    9. Dormann, H; Krebs, S; Muth-Selbach, U; Criegee-Rieck, M; Radespiel-Troger, M; Levy, M; Hahn, EG; Brune, K; Schneider, HT
      Adverse drug reactions in patients with gastroenterological diseases: doesage increase the risk?

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    10. Maihofner, C; Schlotzer-Schrehardt, U; Guhring, H; Zeilhofer, HU; Naumann, GOH; Pahl, A; Mardin, C; Tamm, ER; Brune, K
      Expression of cyclooxygenase-1 and-2 in normal and glaucomatous human eyes

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    11. Damm, J; Rau, T; Maihofner, C; Pahl, A; Brune, K
      Constitutive expression and localization of COX-1 and COX-2 in rabbit irisand ciliary body

      EXPERIMENTAL EYE RESEARCH
    12. Guhring, H; Schuster, J; Hamza, M; Ates, M; Kotalla, CE; Brune, K
      HU-210 shows higher efficacy and potency than morphine after intrathecal administration in the mouse formalin test

      EUROPEAN JOURNAL OF PHARMACOLOGY
    13. Brugger, R; Reichel, C; Alia, BG; Brune, K; Yamamoto, T; Tegeder, I; Geisslinger, G
      Expression of rat liver long-chain acyl-CoA synthetase and characterization of its role in the metabolism of R-ibuprofen and other fatty acid-like xenobiotics (vol 61, pg 651, 2001)

      BIOCHEMICAL PHARMACOLOGY
    14. Brugger, R; Reichel, C; Alia, BG; Brune, K; Yamamoto, T; Tegeder, I; Geissinger, G
      Expression of rat liver long-chain acyl-CoA synthetase and characterization of its role in the metabolism of R-ibuprofen and other fatty acid-like xenobiotics

      BIOCHEMICAL PHARMACOLOGY
    15. Ramer, R; Brune, K; Pahl, A; Hinz, B
      R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    16. Brune, K
      The science of pharmacology: a plea for joining forces

      TRENDS IN PHARMACOLOGICAL SCIENCES
    17. Werner, U; Brune, K; Layh, B; Guehring, H
      Determination of L-iminoethyl-L-lysine in serum by liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    18. Hartner, A; Pahl, A; Brune, K; Goppelt-Struebe, M
      Upregulation of cyclooxygenase-1 and the PGE(2) receptor EP2 in rat and human mesangioproliferative glomerulonephritis

      INFLAMMATION RESEARCH
    19. Diener, HC; Brune, K; Gerber, WD; Pfaffenrath, V; Straube, A
      Therapy of the acute migraine attack and migraine prophylaxis. Recommendation of the "Deutsche Migrane- und Kopfschmerz-Gesellschaft"

      SCHMERZ
    20. Brune, K; Lemmer, B
      Is homeopathic medicine on the same level as Diclofenac?

      SCHMERZ
    21. Lotsch, J; Kettenmann, B; Renner, B; Drover, D; Brune, K; Geisslinger, G; Kobal, G
      Population pharmacokinetics of fast release oral diclofenac in healthy volunteers: Relation to pharmacodynamics in an experimental pain model

      PHARMACEUTICAL RESEARCH
    22. Diener, HC; Brune, K; Gerber, WD; Pfaffenrath, V; Straube, A
      Therapy of migraine attack and migraine prophylaxis - Recommendations of the German Migraine and Headache Society

      NERVENHEILKUNDE
    23. Grosser, K; Oelkers, R; Hummel, T; Geisslinger, G; Brune, K; Kobal, G; Lotsch, J
      Olfactory and trigeminal event-related potentials in migraine

      CEPHALALGIA
    24. Maihofner, C; Tegeder, I; Euchenhofer, C; Dewitt, D; Brune, K; Bang, R; Neuhuber, W; Geisslinger, G
      Localization and regulation of cyclo-oxygenase-1 and-2 and neuronal nitricoxide synthase in mouse spinal cord

      NEUROSCIENCE
    25. Diener, HC; Brune, K; Gerber, WD; Pfaffenrath, V; Straube, A
      Therapy of migraine attacks and migraine prophylaxis - Recommendations by the German Society for Migraine and Headache (DMKG)

      AKTUELLE NEUROLOGIE
    26. Guhring, H; Gorig, M; Ates, M; Coste, O; Zeilhofer, HU; Pahl, A; Rehse, K; Brune, K
      Suppressed injury-induced rise in spinal prostaglandin E-2 production and reduced early thermal hyperalgesia in iNOS-deficient mice

      JOURNAL OF NEUROSCIENCE
    27. Dormann, H; Krebs, S; Muth-Selbach, U; Brune, K; Schuppan, D; Hahn, EG; Schneider, HT
      Rapid onset of hematotoxic effects after interferon alpha in hepatitis C

      JOURNAL OF HEPATOLOGY
    28. Dormann, H; Muth-Selbach, U; Krebs, S; Criegee-Rieck, M; Tegeder, I; Schneider, HT; Hahn, EG; Levy, M; Brune, K; Geisslinger, G
      Incidence and costs of adverse drug reactions during hospitalisation - Computerised monitoring versus stimulated spontaneous reporting

      DRUG SAFETY
    29. Brune, K; Lemmer, B
      Is homeopathic medicine on the same level as Diclofenac?

      ORTHOPADE
    30. Puhl, W; Bernau, A; Bohle, E; Brune, K; Gerhardt, P; Greitemann, B; Gunther, KP; Heber, F; Hof, N; Holfelder, G; Noack, W; Zeilhofer, HU
      Diagnosis and treatment of knee osteoarthritis in outpatients.

      ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE
    31. Geisslinger, G; Muth-Selbach, U; Coste, O; Vetter, G; Schrodter, A; Schaible, HG; Brune, K; Tegeder, I
      Inhibition of noxious stimulus-induced spinal prostaglandin E-2 release byflurbiprofen enantiomers: A microdialysis study

      JOURNAL OF NEUROCHEMISTRY
    32. Bang, N; Pecht, A; Raddatz, G; Scior, T; Solbach, W; Brune, K; Pahl, A
      Prolyl isomerases in a minimal cell - Catalysis of protein folding by trigger factor from Mycoplasma genitalium

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    33. Hinz, B; Brune, K; Pahl, A
      Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E-2, and nonsteroidal anti-inflammatory drugs

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    34. Hinz, B; Kraus, V; Pahl, A; Brune, K
      Salicylate metabolites inhibit cyclooxygenase-2-dependent prostaglandin E-2 synthesis in murine macrophages

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    35. Hinz, B; Brune, K; Pahl, A
      Prostaglandin E-2 upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    36. Hinz, B; Brune, K; Pahl, A
      Nitric oxide inhibits inducible nitric oxide synthase mRNA expression in RAW 264.7 macrophages

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    37. Hinz, B; Brune, K
      Specific COX-2 inhibitors. Basis and options of a pharmacotherapeutical concept

      ANAESTHESIST
    38. Schumann, J; Wolf, D; Pahl, A; Brune, K; Papadopoulos, T; van Rooijen, N; Tiegs, G
      Importance of Kupffer cells for T-cell-dependent liver injury in mice

      AMERICAN JOURNAL OF PATHOLOGY
    39. Krebs, S; Dormann, H; Hahn, EG; Schneider, HT; Brune, K
      Adverse drug reactions. Avoiding, reporting and early intervention by a computer-based sentinal system

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    40. Tegeder, I; Levy, M; Muth-Selbach, U; Oelkers, R; Neumann, F; Dormann, H; Azaz-Livshits, T; Criegee-Rieck, M; Schneider, HT; Hahn, EG; Brune, K; Geisslinger, G
      Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    41. Pahl, A; Kuhlbrandt, U; Brune, K; Rollinghoff, M; Gessner, A
      Quantitative detection of Borrelia burgdorferi by real-time PCR

      JOURNAL OF CLINICAL MICROBIOLOGY
    42. Hinz, B; Brune, K
      Specific COX-2 inhibitors: Perspectives of a therapy with novel analgesic and antiinflammatory substances

      WIENER KLINISCHE WOCHENSCHRIFT
    43. Levy, M; Azaz-Livshits, T; Sadan, B; Shalit, M; Geisslinger, G; Brune, K
      Computerized surveillance of adverse drug reactions in hospital: Implementation

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    44. Bang, H; Muller, W; Hans, M; Brune, K; Swandulla, D
      Activation of Ca2+ signaling in neutrophils by the mast cell-released immunophilin FKBP12 (vol 92, pg 3435, 1995)

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    45. Tegeder, I; Lotsch, J; Krebs, S; Muth-Selbach, U; Brune, K; Geisslinger, G
      Comparison of inhibitory effects of meloxicam and diclofenac on human thromboxane biosynthesis after single doses and at steady state

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    46. Tegeder, I; Muth-Selbach, U; Lotsch, J; Rusing, G; Oelkers, R; Brune, K; Meller, S; Kelm, GR; Sorgel, F; Geisslinger, G
      Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    47. Tegeder, I; Neumann, F; Bremer, F; Brune, K; Lotsch, J; Geisslinger, G
      Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    48. Oelkers, R; Grosser, K; Lang, E; Geisslinger, G; Kobal, G; Brune, K; Lotsch, J
      Visual evoked potentials in migraine patients: alterations depend on pattern spatial frequency

      BRAIN
    49. Muth-Selbach, US; Tegeder, I; Brune, K; Geisslinger, G
      Acetaminophen inhibits spinal prostaglandin E-2 release after peripheral noxious stimulation

      ANESTHESIOLOGY
    50. Brune, K
      Antipyretic analgesic drugs

      MARIHUANA AND MEDICINE
    51. Beiche, F; Brune, K; Geisslinger, G; Goppelt-Struebe, M
      Expression of cyclooxygenase isoforms in the rat spinal cord and their regulation during adjuvant-induced arthritis

      INFLAMMATION RESEARCH
    52. PFAFFENRATH V; BRUNE K; DIENER HC; GERBER WD; GOBEL H
      THE TREATMENT OF TENSION-TYPE HEADACHE - GUIDELINES OF THE GERMAN-MIGRAINE-AND-HEADACHE-SOCIETY

      Nervenheilkunde
    53. AZAZLIVSHITS T; LEVY M; SADAN B; SHALIT M; GEISSLINGER G; BRUNE K
      COMPUTERIZED SURVEILLANCE OF ADVERSE DRUG-REACTIONS IN-HOSPITAL - PILOT-STUDY

      British journal of clinical pharmacology
    54. EUCHENHOFER C; MAIHOFNER C; BRUNE K; TEGEDER I; GEISSLINGER G
      DIFFERENTIAL EFFECT OF SELECTIVE CYCLOOXYGENASE-2 (COX-2) INHIBITOR NS-398 AND DICLOFENAC ON FORMALIN-INDUCED NOCICEPTION IN THE RAT

      Neuroscience letters
    55. DORMANN H; BERG P; MEYER M; GEISSLINGER G; SCHUPPAN D; BRUNE K; HAHN EG; SCHNEIDER HT
      HEMATOLOGICAL TOXICITY OF INTERFERON-ALPHA IN HEPATITIS-C A KINETIC-STUDY

      Hepatology
    56. RASCHER C; PAHL A; PECHT A; BRUNE K; SOLBACH W; BANG H
      LEISHMANIA-MAJOR PARASITES EXPRESS CYCLOPHILIN ISOFORMS WITH AN UNUSUAL INTERACTION WITH CALCINEURIN

      Biochemical journal
    57. BRUNE K
      NEW STRATEGIES AGAINST INFECTIONS

      Naunyn-Schmiedeberg's archives of pharmacology
    58. ZEILHOFER HU; VESTWEBER D; SWANDULLA D; BRUNE K; HALLMAN R
      E-SELECTIN-INDUCED CALCIUM SIGNALING AND ADHESION IN NEUTROPHIL GRANULOCYTES

      Naunyn-Schmiedeberg's archives of pharmacology
    59. GUEHRING H; PAHL A; REEH P; BRUNE K; GEISSLINGER G
      ANTINOCICEPTIVE AND ANTIINFLAMMATORY EFFECTS OF COX AND NOS INHIBITORS - ROLE OF COX-2 AND INOS IN NOCICEPTIVE PROCESSING IN SPINAL-CORD AND IN INFLAMED PAW OF RATS

      Naunyn-Schmiedeberg's archives of pharmacology
    60. HINZ B; BRUNE K; PAHL A
      NITRIC-OXIDE DECREASES INDUCIBLE NITRIC-OXIDE SYNTHASE MESSENGER-RNA LEVELS IN MURINE MACROPHAGES

      Naunyn-Schmiedeberg's archives of pharmacology
    61. BRUGGER R; REICHEL C; BRUNE K; GEISSLINGER G
      NEW INSIGHTS INTO THE PHYSIOLOGICAL-ROLE OF 2-ARYLPROPIONYL-COA EPIMERASE

      Naunyn-Schmiedeberg's archives of pharmacology
    62. SCHEUREN N; BANG H; MUNSTER T; BRUNE K; PAHL A
      ENANTIOMERS OF THE NONSTEROIDAL ANTIINFLAMMATORY DRUG IBUPROFEN ARE POTENT AND SPECIFIC INHIBITORS OF TRANSCRIPTION FACTOR NF-KAPPA-B

      Naunyn-Schmiedeberg's archives of pharmacology
    63. GUEHRING H; PAHL A; REEH P; BRUNE K; GEISSLINGER G
      ROLE OF CYCLOOXYGENASE (COX)-2 ON THERMAL HYPERALGESIA EVOKED BY ZYMOSAN INJECTION IN THE RAT

      Naunyn-Schmiedeberg's archives of pharmacology
    64. HINZ B; GEISSLINGER G; BRUNE K; PAHL A
      EFFECT OF IBUPROFEN ON THE EXPRESSION OF CYCLOOXYGENASE-2 AND INDUCIBLE NITRIC-OXIDE SYNTHASE IN MURINE RAW-264.7 MACROPHAGES

      Naunyn-Schmiedeberg's archives of pharmacology
    65. BREMER F; LOTSCH J; BRUNE K; SCHUTTLER J; GEISSLINGER G; TEGEDER I
      COMPARISON OF PHARMACOKINETICS OF MEROPENEM AND IMIPENEM IN CRITICALLY ILL PATIENTS WITH ACUTE-RENAL-FAILURE UNDERGOING CONTINUOUS VENOVENOUS HEMOFILTRATION

      Naunyn-Schmiedeberg's archives of pharmacology
    66. LOTSCH J; WEISS M; AHNE G; BRUNE K; KOBAL G; GEISSLINGER G
      PHARMACOKINETIC MODELING OF M6G FORMATION AFTER ORAL AND INTRAVENOUS ADMINISTRATION OF MORPHINE IN HEALTHY-VOLUNTEERS

      Naunyn-Schmiedeberg's archives of pharmacology
    67. TEGEDER I; MUTHSELBACH U; OELKERS R; LOTSCH J; BRUNE K; SORGEL F; GEISSLINGER G
      APPLICATION OF HUMAN MICRODIALYSIS FOR THE EVALUATION OF TISSUE IBUPROFEN CONCENTRATIONS AFTER PERORAL AND TOPICAL ADMINISTRATION

      Naunyn-Schmiedeberg's archives of pharmacology
    68. MUTHSELBACH U; TEGEDER I; KREBS S; NEUPERT W; BRUNE K; GEISSLINGER G
      EFFECTS OF MELOXICAM AND DICLOFENAC ON HUMAN THROMBOXANE BIOSYNTHESIS

      Naunyn-Schmiedeberg's archives of pharmacology
    69. SCHEUERER S; WILLIAMS KM; BRUGGER R; MCLACHLAN AJ; BRUNE K; DAY RO; GEISSLINGER G
      EFFECT OF CLOFIBRATE ON THE CHIRAL DISPOSITION OF IBUPROFEN IN RATS

      The Journal of pharmacology and experimental therapeutics
    70. LEVY M; BRUNE K; ZYLBERKATZ E; COHEN O; CARACO Y; GEISSLINGER G
      CEREBROSPINAL-FLUID PROSTAGLANDINS AFTER SYSTEMIC DIPYRONE INTAKE

      Clinical pharmacology and therapeutics
    71. LOTSCH J; GROSSER K; OELKERS R; BRUNE K; LANG E; GEISSLINGER G; KOBAL G
      NASAL CHEMOSENSITIVITY IN HEADACHE - INDICATIONS FOR THE NEURONAL THEORY OF PATHOGENESIS OF MIGRAINE

      Clinical pharmacology and therapeutics
    72. SCHEUREN N; BANG H; MUNSTER T; BRUNE K; PAHL A
      MODULATION OF TRANSCRIPTION FACTOR NF-KAPPA-B BY ENANTIOMERS OF THE NONSTEROIDAL DRUG IBUPROFEN

      British Journal of Pharmacology
    73. PAHL A; BRUNE K; BANG H
      FIT FOR LIFE - EVOLUTION OF CHAPERONES AND FOLDING CATALYSTS PARALLELS THE DEVELOPMENT OF COMPLEX ORGANISMS

      Cell stress & chaperones
    74. ERB K; LIEBEL JT; TEGEDER I; ZEILHOFER HU; BRUNE K; GEISSLINGER G
      SPINALLY DELIVERED NOCICEPTIN ORPHANIN FQ REDUCES FLINCHING BEHAVIOR IN THE RAT FORMALIN TEST/

      NeuroReport
    75. HOERAUF A; RASCHER C; BANG R; PAHL A; SOLBACH W; BRUNE K; ROLLINGHOFF M; BANG H
      HOST-CELL CYCLOPHILIN IS IMPORTANT FOR THE INTRACELLULAR REPLICATION OF LEISHMANIA-MAJOR

      Molecular microbiology
    76. DIENER HC; BRUNE K; GERBER WD; GOBEL H; PFAFFENRATH V
      THERAPY OF ACUTE MIGRAINE ATTACKS AND MIG RAINE PROPHYLAXIS - GUIDELINES OF THE GERMAN-MIGRAINE-AND-HEADACHE-SOCIETY

      Nervenheilkunde
    77. OELKERS R; NEUPERT W; WILLIAMS KM; BRUNE K; GEISSLINGER G
      DISPOSITION AND EFFECTS OF FLURBIPROFEN ENANTIOMERS IN HUMAN SERUM AND BLISTER FLUID

      British journal of clinical pharmacology
    78. GEISSLINGER G; BRUNE K; KOBAL G; LOTSCH J
      INTRAVENOUS MORPHINE-6-GLUCURONIDE (M6G) IS DEVOID OF ANALGESIC ACTIVITY IN MAN

      Pain
    79. TEGEDER I; SCHUMACHER A; JOHN S; GEIGER H; GEISSLINGER G; BANG H; BRUNE K
      ELEVATED SERUM CYCLOPHILIN LEVELS IN PATIENTS WITH SEVERE SEPSIS

      Journal of clinical immunology
    80. BRUNE K
      SELECTIVE CYCLOOXYGENASE-2 (COX-2) INHIBITOR - BELIEF, REALITY AND HOPE

      Der Orthopade
    81. TEGEDER I; BREMER F; OELKERS R; SCHOBEL H; SCHUTTLER J; BRUNE K; GEISSLINGER G
      PHARMACOKINETICS OF IMIPENEM-CILASTATIN IN CRITICALLY ILL PATIENTS UNDERGOING CONTINUOUS VENOVENOUS HEMOFILTRATION

      Antimicrobial agents and chemotherapy
    82. SCHEUERER S; BRUGGER R; WILLIAMS KM; BRUNE K; GEISSLINGER G
      EFFECT OF CLOFIBRATE ON THE STEREOSELECTIVE UPTAKE OF IBUPROFEN INTO VARIOUS TISSUES

      Naunyn-Schmiedeberg's archives of pharmacology
    83. BRUGGER R; REICHEL C; ALIA BG; BRUNE K; YAMAMOTO T; GEISSLINGER G
      ROLE OF LONG-CHAIN ACYL-COA SYNTHETASE IN THE METABOLISM OF IBUPROFENAND OTHER FATTY-ACID LIKE XENOBIOTICS

      Naunyn-Schmiedeberg's archives of pharmacology
    84. BEICHE F; BRUNE K; GEISSLINGER G; GOPPELTSTRUBE M
      CYCLOOXYGENASE ISOFORM EXPRESSION IN THE RAT SPINAL-CORD FOLLOWING PERIPHERAL INFLAMMATION

      Naunyn-Schmiedeberg's archives of pharmacology
    85. ERB K; LIEBEL J; ZEILHOFER HU; BRUNE K; GEISSLINGER G
      IS NOCICEPTIN ANTINOCICEPTIVE

      Naunyn-Schmiedeberg's archives of pharmacology
    86. OELKERS R; GROSSER K; LOTSCH J; LANG E; BRUNE K; GEISSLINGER G; KOBAL G
      PATTERN-REVERSAL VISUAL-EVOKED POTENTIALS AT DIFFERENT SPATIAL-FREQUENCIES IN MIGRAINE

      Naunyn-Schmiedeberg's archives of pharmacology
    87. LOTSCH J; KOBAL G; STOCKMANN A; BRUNE K; GEISSLINGER G
      PHARMACOKINETICS OF MORPHINE AND ITS GLUCURONIDES IN HEALTHY-VOLUNTEERS

      Naunyn-Schmiedeberg's archives of pharmacology
    88. NEUPERT W; BRUGGER R; BRUNE K; GEISSLINGER G
      STEREOSELECTIVE INHIBITION OF CYCLOOXYGENASE-1 (COX-1) AND COX-2 BY IBUPROFENOYL-COA-THIOESTERS AND IBUPROFEN ENANTIOMERS

      Naunyn-Schmiedeberg's archives of pharmacology
    89. TEGEDER I; BREMER F; OELKERS R; SCHUTTLER J; BRUNE K; GEISSLINGER G
      THERAPEUTIC DRUG-MONITORING OF IMIPENEM DURING CONTINUOUS VENOVENOUS HEMOFILTRATION

      Naunyn-Schmiedeberg's archives of pharmacology
    90. REICHEL C; BRUGGER R; BANG H; GEISSLINGER G; BRUNE K
      MOLECULAR-CLONING AND EXPRESSION OF A 2-ARYLPROPIONYL-COENZYME-A EPIMERASE - A KEY ENZYME IN THE INVERSION METABOLISM OF IBUPROFEN

      Molecular pharmacology
    91. SCHEUREN N; NEUPERT W; IONAC M; NEUHUBER W; BRUNE K; GEISSLINGER G
      PERIPHERAL NOXIOUS-STIMULATION RELEASES SPINAL PGE2 DURING THE FIRST-PHASE IN THE FORMALIN ASSAY OF THE RAT

      Life sciences
    92. NEUPERT W; BRUGGER R; EUCHENHOFER C; BRUNE K; GEISSLINGER G
      EFFECTS OF IBUPROFEN ENANTIOMERS AND ITS COENZYME-A THIOESTERS ON HUMAN PROSTAGLANDIN ENDOPEROXIDE SYNTHASES

      British Journal of Pharmacology
    93. LOTSCH J; KOBAL G; STOCKMANN A; BRUNE K; GEISSLINGER G
      LACK OF ANALGESIC ACTIVITY OF MORPHINE-6-GLUCURONIDE AFTER SHORT-TERMINTRAVENOUS ADMINISTRATION IN HEALTHY-VOLUNTEERS

      Anesthesiology
    94. GEISSLINGER G; MENZEL S; BRUNE K
      STEREOSPECIFIC DETERMINATION OF TIAPROFENIC ACID IN PLASMA - PROBLEMSWITH DRUG DEGRADATION

      Journal of chromatography B. Biomedical applications
    95. PAHL A; BANG R; RASCHER C; BRUNE K; BANG H
      CYCLOPHILINS IN A PARASITIC DISEASE - LEISHMANIASIS

      Molecular biology of the cell
    96. BANG H; PAHL A; BANG R; BRUNE K
      NUCLEOCYTOPLASMIC SHUTTLING OF CYCLOPHILIN REGULATED BY HEAT-SHOCK RESPONSE

      Molecular biology of the cell
    97. IONAC M; PARNHAM MJ; PLAUCHITHIU M; BRUNE K
      OXACEPROL, AN ATYPICAL INHIBITOR OF INFLAMMATION AND JOINT DAMAGE

      Pharmacological research
    98. GEISSLINGER C; BRUNE K; GOPPELTSTRUBE M
      COX-1 AND COX-2 INHIBITION - WISH AND REA LITY OF A SPECIFIC THERAPY WITH NONSTEROIDAL ANTIRHEUMATICS

      Aktuelle Rheumatologie
    99. GEISSLINGER G; PESKAR BA; PALLAPIES D; SITTL R; LEVY M; BRUNE K
      THE EFFECTS ON PLATELET-AGGREGATION AND PROSTANOID BIOSYNTHESIS OF 2 PARENTERAL ANALGESICS - KETOROLAC TROMETHAMINE AND DIPYRONE

      Thrombosis and haemostasis
    100. OELKERS R; IONAC M; ERB K; BRUNE K; GEISSLINGER G
      TRANSFER OF DIFFERENT NONSTEROIDAL ANTIINFLAMMATORY DRUGS VIA THE LYMPHATIC-SYSTEM IN THE RAT

      Drug metabolism and disposition


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/08/20 alle ore 15:48:37